About / standards
How this site thinks, selects, and writes
Peptide Ledger is built to feel calm because the subject is often made noisier than it needs to be. The aim is not to sell a peptide story. It is to explain a peptide field.
Editorial principles
Five rules guide the entire publication
The site uses a deliberately restrained framework so readers can understand what is known, what is promising, and what remains uncertain.
How information is selected
We prefer dependable scaffolding over exhaustive citation theater.
The site is written from a curated base of reputable medical institutions, regulatory materials, peer-reviewed reviews, and high-trust educational resources. The goal is not to overwhelm readers with references, but to make sure the copy rests on stable ground.
What we do not do
This is not a clinic, a supplement funnel, or a sourcing guide.
We do not give dosage advice, cycle advice, procurement advice, or promises about healing, performance, fat loss, skin reversal, or longevity. Personal decisions belong with a licensed clinician, not with generalized editorial content.
FAQ
Frequently asked questions
A fuller set of questions about definitions, evidence, safety, and the editorial boundaries of this site.
A peptide is a short chain of amino acids linked by peptide bonds. In practice, that simple definition covers many different realities: natural signaling molecules in the body, approved medicines, cosmetic ingredients, nutritional fragments, and experimental compounds discussed online.
Core source set
Peptide
National Human Genome Research Institute
Clear definition of peptides as short amino-acid chains and a useful starting point for plain-language explanation.
Protein
National Human Genome Research Institute
Defines proteins as larger, folded amino-acid chains and helps frame the peptide-versus-protein distinction.
Clinical Pharmacology Considerations for Peptide Drug Products
U.S. Food and Drug Administration
Shows how regulators think about peptide drug products and why structure alone does not determine clinical meaning.
Human Insulin Injection
MedlinePlus
A medication-focused overview of insulin’s role in blood-sugar regulation and standard clinical use.
FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss
U.S. Food and Drug Administration
Useful for explaining why established peptide medicines should not be conflated with unapproved, compounded, or counterfeit products.
Collagen Supplementation for Skin Health: A Mechanistic Systematic Review
PubMed
A systematic review used to discuss the more cautious, evidence-aware view of oral collagen peptides and skin claims.
Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data
International Journal of Molecular Sciences / PMC
A mechanistic review often cited in discussion of GHK-Cu, helpful for background but not a substitute for large clinical trials.
Usage of Synthetic Peptides in Cosmetics for Sensitive Skin
Pharmaceuticals / PMC
Useful because it explicitly notes that topical peptide evidence is uneven and frequently supported by limited clinical data.
Anti-Wrinkle Benefits of Peptides Complex Stimulating Skin Basement Membrane Proteins Expression
International Journal of Molecular Sciences / PMC
A small clinical-plus-lab study that helps frame wrinkle-related topical peptide claims as promising but still formulation-specific.
FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss
U.S. Food and Drug Administration
Useful for explaining why established peptide medicines should not be conflated with unapproved, compounded, or counterfeit products.
BPC-157: Experimental Peptide Creates Risk for Athletes
U.S. Anti-Doping Agency
Directly relevant for explaining why BPC-157 remains experimental, unapproved for human clinical use, and widely overstated online.